Soluble CD40 ligand induces β-chemokine production by macrophages and resistance to HIV-1 entry

被引:20
作者
Di Marzio, P
Mariani, R
Lui, R
Thomas, EK
Landau, NR
机构
[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10016 USA
[2] Immunex Res & Dev Corp, Seattle, WA 98101 USA
关键词
CD40L; HIV-1; macrophages;
D O I
10.1006/cyto.1999.0594
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
CD40 ligand (CD40L) is a cell surface molecule of CD4(+) T cells that interacts with its receptor CD40 on antigen presenting cells to mediate thymus-dependent humoral immunity and inflammatory reactions. We report here that treating monocyte-derived macrophages (MDM) with a trimeric soluble form of CD40L (CD40LT) induced them to secrete high levels of the beta -chemokines RANTES, MIP-1 alpha and MIP-1 beta that are ligands for CCR5 and able to inhibit HIV-1 entry. CD40LT inhibited the entry of M-tropic HIV-1 reporter viruses. Furthermore, supernatants obtained from CD40LT-stimulated macrophages protected CEMx174-CCR5 cells from infection by HIV-1(JRFL) reporter virus. The inhibitory activity appeared to be due to beta -chemokines present in the supernatant, since pretreating them with a cocktail of antibodies to RANTES, MIP-1 alpha and MIP-1 beta neutralized the inhibitory activity of the supernatants, In addition, treating monocytes with CD40LT caused CCR5 and CD4 to be downregulated from the cell surface. In vivo, macrophages activated through CD40 could interfere with HIV replication. (C) 2000 Academic Press.
引用
收藏
页码:1489 / 1495
页数:7
相关论文
共 29 条
  • [1] CD40 EXPRESSION BY HUMAN MONOCYTES - REGULATION BY CYTOKINES AND ACTIVATION OF MONOCYTES BY THE LIGAND FOR CD40
    ALDERSON, MR
    ARMITAGE, RJ
    TOUGH, TW
    STROCKBINE, L
    FANSLOW, WC
    SPRIGGS, MK
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) : 669 - 674
  • [2] THE CD40 ANTIGEN AND ITS LIGAND
    BANCHEREAU, J
    BAZAN, F
    BLANCHARD, D
    BRIERE, F
    GALIZZI, JP
    VANKOOTEN, C
    LIU, YJ
    ROUSSET, F
    SAELAND, S
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 : 881 - 922
  • [3] Inhibition of HIV type 1 BaL replication by MIP-1α, MIP-1β, and RANTES in macrophages
    Capobianchi, MR
    Abbate, I
    Antonelli, G
    Turriziani, O
    Dolei, A
    Dianzani, F
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (03) : 233 - 240
  • [4] CHIRMULE N, 1995, J IMMUNOL, V155, P917
  • [5] IDENTIFICATION OF RANTES, MIP-1-ALPHA, AND MIP-1-BETA AS THE MAJOR HIV-SUPPRESSIVE FACTORS PRODUCED BY CD8(+) T-CELLS
    COCCHI, F
    DEVICO, AL
    GARZINODEMO, A
    ARYA, SK
    GALLO, RC
    LUSSO, P
    [J]. SCIENCE, 1995, 270 (5243) : 1811 - 1815
  • [6] CONNOR RI, 1995, VIROLOGY, V206, P936
  • [7] Di Marzio P, 1998, AIDS RES HUM RETROV, V14, P129, DOI 10.1089/aid.1998.14.129
  • [8] CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy
    Diehl, L
    den Boer, AT
    Schoenberger, SP
    van der Voort, EIH
    Schumacher, TNM
    Melief, CJM
    Offringa, R
    Toes, REM
    [J]. NATURE MEDICINE, 1999, 5 (07) : 774 - 779
  • [9] HIV-1 entry into CD4(+) cells is mediated by the chemokine receptor CC-CKR-5
    Dragic, T
    Litwin, V
    Allaway, GP
    Martin, SR
    Huang, YX
    Nagashima, KA
    Cayanan, C
    Maddon, PJ
    Koup, RA
    Moore, JP
    Paxton, WA
    [J]. NATURE, 1996, 381 (6584) : 667 - 673
  • [10] THE ROLE OF CD40 IN THE REGULATION OF HUMORAL AND CELL-MEDIATED-IMMUNITY
    DURIE, FH
    FOY, TM
    MASTERS, SR
    LAMAN, JD
    NOELLE, RJ
    [J]. IMMUNOLOGY TODAY, 1994, 15 (09): : 406 - 411